CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy

Yildirim, Fatma; KARADUMAN, AYŞEN; PINAR, ASLI; AKSOY, YASEMİN

doi:10.1111/j.1365-4632.2010.04799.x

CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy

Atıf İçin Kopyala

Yildirim F. E., KARADUMAN A., PINAR A., AKSOY Y.

INTERNATIONAL JOURNAL OF DERMATOLOGY, cilt.50, sa.8, ss.948-955, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 50 Sayı: 8
Basım Tarihi: 2011
Doi Numarası: 10.1111/j.1365-4632.2010.04799.x
Dergi Adı: INTERNATIONAL JOURNAL OF DERMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.948-955
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective The aim of this study is to determine serum levels of soluble forms of CD26/dipeptidyl-peptidase IV (DPP-IV) and adenosine deaminase (ADA), thought to be markers of T-cell activation, and changes in their levels in response to cyclosporine, etanercept, and psoralen plus ultraviolet A (PUVA) treatments with respect to disease activity.